Navigation Links
Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Significant Reductions of ApoC-III and Triglycerides in Patients With High Triglycerides Taking Fibrates
Date:7/22/2013

CARLSBAD, Calif., July 22, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced data from a Phase 2 study of ISIS-APOCIIIRx in patients with high to severely high triglycerides on stable doses of fibrates.  In this study, patients treated with ISIS-APOCIIIRx experienced reductions of up to 70 percent in apolipoprotein C-III (apoC-III) and up to 64 percent in triglycerides.  In addition, patients treated with ISIS-APOCIIIRx experienced an up to 52 percent increase in high-density lipoprotein cholesterol (HDL-C), the 'good' cholesterol, and an up to 77 percent reduction in apoC-III-associated very low-density lipoprotein (VLDL) particles.  Isis is also evaluating ISIS-APOCIIIRx in this Phase 2 study as a monotherapy in patients with severely high triglycerides and plans to report these data at the European Society of Cardiology on August 31 in Amsterdam.

The Phase 2 study of ISIS-APOCIII­Rx was a double-blind, randomized, placebo-controlled 13-week study designed to assess the safety and activity of ISIS-APOCIIIRx.  The portion of the study reported today was conducted in patients with high to severely elevated triglyceride levels (between 225 and 2,000 mg/dL) on stable doses of fibrates. 

Table 1:  ISIS-APOCIIIRx Produced Statistically Significant Reductions of Triglycerides, ApoC-III and ApoC-III Associated VLDL in a Phase 2 Study in Patients With High Triglyceride Levels Treated With Stable Doses of Fibrates.  Mean % Changes From Baseline at Primary Endpoint.Placebo + Fibrate

(n=8)

ISIS-APOCIIIRx 200 mg + Fibrate 

(n=8)

ISIS-APOCIIIRx 300 mg + Fibrate

(n=10)ApoC-III

-2.2%

-59.4% (p<0.0001)


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
2. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
3. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
4. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
6. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
7. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
8. Luminex Corporation Reports First Quarter 2012 Results
9. Hospira Reports First-Quarter 2012 Results
10. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
11. The Female Health Company Reports Second Quarter Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... -- Mauna Kea Technologies (Euronext: MKEA, FR0010609263), ... today announced the set-up of an optical biopsy program ... CHU de Grenoble is now the first hospital in ... gastroenterology, interventional pulmonology and urology patients an innovative platform ... thanks to the endomicroscopy technology developed by Mauna Kea ...
(Date:3/31/2015)... N.Y. , March 31, 2015 ... will be featured in the American Medical Group ... ITN Productions. AMGA,s "High Performing Health" ... the challenges facing the nation,s healthcare system in ... Letter is profiled along with other leading organizations ...
(Date:3/31/2015)... Calif. , March 31, 2015  Frequentz Inc., ... has released a white paper to help the pharmaceutical ... 2013 Drug Supply Chain Security Act (DSCSA). The white ... stages of the GS1 EPCIS Standard(s) and ... outlook on the product tracing requirements that need to ...
Breaking Medicine Technology:Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 2Grenoble University Hospital First Hospital in France to set up a Multidisciplinary Optical Biopsy Program With the Cellvizio Endomicroscopy Platform 3AMGA's High Performing Health News Program Features The Medical Letter 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3
... Nov. 9, 2011 GenVec, Inc. (Nasdaq: GNVC ) ... 30, 2011.   GenVec reported a net loss of ... 30, 2011 compared to a net loss of $2.4 million ($0.18 ... months ended September 30, 2011, GenVec,s net loss was $4.9 million ...
... Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical ... companion diagnostics, presents the 2011 ,Debiopharm /Valais Award, ... based in Monthey (Valais), that focuses on point-of-care ... on Celiac disease. Debio R.P., the Martigny-based structure ...
Cached Medicine Technology:GenVec Reports Third Quarter 2011 Financial Results 2GenVec Reports Third Quarter 2011 Financial Results 3GenVec Reports Third Quarter 2011 Financial Results 4GenVec Reports Third Quarter 2011 Financial Results 5Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease 2Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease 3Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease 4Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease 5Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease 6
(Date:4/1/2015)... Enterprise Integration has appeared on ... distinguished list and report identifying the world’s top ... list is currently available on the MSPmentor. Additional ... MSPs in North America ,     The top ...     The top MSPs in Asia, Australia and ...
(Date:3/31/2015)... Michigan (PRWEB) March 31, 2015 On November ... NFL All-Pro Lawrence Taylor to discuss the problem of substance ... through his own history of drug abuse and recovery, gives ... , Nicknamed “L.T.” by his teammates on the New York ... league due to failed drug tests, yet he was able ...
(Date:3/31/2015)... 2015 Dr. Parsa Mohebi, founder of Parsa Mohebi ... on the forefront of using beard hair to fill ... as a novelty has now become an absolute option for giving ... “I really do believe that beard to scalp hair transplant can ... donor area isn’t as dense as we would like it,” says ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Karen A. ... 2015 at Rivier University’s Commencement ceremony on ... of humane letters in recognition of her eminent career ... Serving as a front-line caregiver and senior staff nurse ... years and advancing to leadership roles, including President of ...
(Date:3/31/2015)... Tampa, FL (PRWEB) March 31, 2015 ... of America, has met all criteria for Laboratory Accreditation ... is given only to laboratories that apply rigid standards ... the performance of proficiency testing, and pass a rigorous ... earned COLA accreditation as a result of a long-term ...
Breaking Medicine News(10 mins):Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2
... HealthDay Reporter , TUESDAY, March 1 (HealthDay News) ... and Drug Administration approves medical devices with too little ... FDA approval without being adequately tested on women, despite ... means that heart valves, pacemakers, defibrillators and stents get ...
... (NEI) and Food and Drug Administration (FDA) are sponsoring ... clinical trials of visual prostheses will be analyzed and ... and contrast sensitivity. These assessments may provide valuable information ... Today, functional vision outcomes such as how patients ...
... , TUESDAY, March 1 (HealthDay News) -- Scientists have identified a ... have type 2 diabetes. Although it,s not yet clear how ... among other benefits, say the authors of a study published March ... As with so many gene studies, however, these findings ...
... March 1 (HealthDay News) -- A new international study finds ... elsewhere may be infected with human papillomavirus (HPV), a sexually ... The finding could help public health experts determine the ... say. "The incidence of genital HPV infection in men ...
... review of more than 160 studies of human and animal ... else being equal happy people tend to live longer ... study, in the journal Applied Psychology: Health and Well-Being ... evidence linking happiness to health outcomes. Its lead author, University ...
... is not always a fun time for people with autism. ... during free time, however, can boost their enjoyment, as well ... team of researchers. "For many of us, we look ... are fun and that are designed for our enjoyment," said ...
Cached Medicine News:Health News:Heart Devices Not Tested Enough in Women: Study 2Health News:Heart Devices Not Tested Enough in Women: Study 3Health News:Visual prostheses: Symposium to explore combining functional endpoints 2Health News:Scientists Spot Another Gene Behind Type 2 Diabetes 2Health News:Half of U.S. Men Infected With HPV, Study Reveals 2Health News:Study: Happiness improves health and lengthens life 2Health News:Freedom to choose leisure activities benefits people with autism 2
... a complete line of flowmeters, available in oxygen, air, ... in a variety of calibrations to best suit your ... the gas in use, the Amvex Flowmeter is a ... U with I. For Power Take-Off add PT to ...
0-3.5 LPM Oxygen Flowmeter 1/8" NPT Female inlet...
(1-15 LPM), 50 psi, 1/ 8" NPT female back inlet...
... style oxygen flowmeters., ,Options: ... suffix S to model number. ... Color-Code, add suffix C to ... For Double Flowmeters with Power ...
Medicine Products: